FdaApplication

NDA 214938

Back to search

Identifiers

Properties

PropertyValue
applicant_nameBIOMARIN PHARMACEUTICAL INC
application_typeNDA
approval_date2021-11-19

Products (3)

ProductActive ingredientStrengthDosage form
VOXZOGOVOSORITIDE0.56MG/VIALPOWDER;SUBCUTANEOUS
VOXZOGOVOSORITIDE0.4MG/VIALPOWDER;SUBCUTANEOUS
VOXZOGOVOSORITIDE1.2MG/VIALPOWDER;SUBCUTANEOUS

3 products